QUVA PHARMA

Serial Number 87812712
Registration 5599552
702

Registration Progress

Application Filed
Feb 27, 2018
Under Examination
Approved for Publication
Aug 21, 2018
Published for Opposition
Aug 21, 2018
Registered
Nov 6, 2018

Trademark Image

QUVA PHARMA

Basic Information

Serial Number
87812712
Registration Number
5599552
Filing Date
February 27, 2018
Registration Date
November 6, 2018
Published for Opposition
August 21, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Mar 6, 2025
Registration
Registered
Classes
040

Rights Holder

QuVa Pharma, Inc.

03
Address
3 Sugar Creek Center Blvd,
Suite 250
Sugar Land, TX 77478

Ownership History

QuVa Pharma, Inc.

Original Applicant
03
Sugar Land, TX

QuVa Pharma, Inc.

Owner at Publication
03
Sugar Land, TX

QuVa Pharma, Inc.

Original Registrant
03
Sugar Land, TX

Legal Representation

Attorney
Danielle I. Mattessich

USPTO Deadlines

Next Deadline
1040 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20181106)
Due Date
November 06, 2028
Grace Period Ends
May 06, 2029

Application History

23 events
Date Code Type Description Documents
Mar 6, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Mar 6, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Mar 6, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 4, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 6, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 6, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 6, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 6, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Nov 6, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 21, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 21, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 1, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 16, 2018 ALIE A ASSIGNED TO LIE Loading...
Jul 1, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 26, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 25, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 25, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 21, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 21, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 21, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 12, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 6, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 2, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Custom manufacture of medications by pharmaceutical compounders
First Use Anywhere: May 28, 2015
First Use in Commerce: May 28, 2015

Classification

International Classes
040

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"